Share on StockTwits

Mead Johnson Nutrition Co. (NYSE:MJN) issued an update on its FY14 earnings guidance on Thursday morning. The company provided earnings per share guidance of $3.50-3.62 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.62, StockRatingsNetwork reports.

Mead Johnson Nutrition Co. (NYSE:MJN) traded up 2.34% on Thursday, hitting $80.47. The stock had a trading volume of 984,437 shares. Mead Johnson Nutrition Co. has a 1-year low of $66.80 and a 1-year high of $86.87. The stock’s 50-day moving average is $79.96 and its 200-day moving average is $79.55. The company has a market cap of $16.221 billion and a price-to-earnings ratio of 24.65.

Mead Johnson Nutrition (NYSE:MJN) last announced its earnings results on Friday, January 31st. The company reported $0.78 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.77 by $0.01. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter last year, the company posted $0.72 earnings per share. Mead Johnson Nutrition’s revenue was up 8.0% compared to the same quarter last year. On average, analysts predict that Mead Johnson Nutrition Co. will post $3.62 earnings per share for the current fiscal year.

A number of analysts have recently weighed in on MJN shares. Analysts at Morgan Stanley raised their price target on shares of Mead Johnson Nutrition to $85.00 in a research note on Wednesday. They now have an equal weight rating on the stock. On a related note, analysts at Wells Fargo & Co. upgraded shares of Mead Johnson Nutrition from a market perform rating to an outperform rating in a research note on Monday, February 10th. Finally, analysts at Socgen initiated coverage on shares of Mead Johnson Nutrition in a research note on Friday, January 31st. They set a buy rating on the stock. Seven investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. The company has an average rating of Buy and a consensus price target of $87.85.

In other Mead Johnson Nutrition news, Director Stephen Golsby sold 10,000 shares of the stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $77.78, for a total value of $777,800.00. Following the sale, the director now directly owns 80,920 shares of the company’s stock, valued at approximately $6,293,958. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Mead Johnson Nutrition Company (NYSE:MJN) is a global pediatric nutrition company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.